Local, prospective, multicenter, non-comparative, non-interventional, observational study. It is planed to assess compliance of patients with PH (pulmonary hypertension) with the physician's recommendation in real practice.
Study Type
OBSERVATIONAL
Enrollment
89
Unnamed facility
Multiple Locations, Russia
Number of days without any drug administration at all
Time frame: Up to 12 months
Number of fully inhaled doses in relation to the total number of inhalations per day
Time frame: Up to 12 months
Number of missed doses per day as recommended
Time frame: Up to 12 months
Number of actually inhaled doses per day vs. the recommended number of inhalations - either as recommended by the treating physician or as recommended by the label
Time frame: Up to 12 months
6 minute walking distance test (MWDT) value
Time frame: Up to 12 months
Score on dyspnea Borg CR (category ratio) 10 scale
Time frame: Up to 12 months
Patients' quality of life, assessed by validated questionnaire
Time frame: Up to 12 months
Assessment of the structural changes in the lungs using X-ray examination of the lungs
Time frame: Up to 12 months
Assessment of the structural changes in the lungs using spirography
Time frame: Up to 12 months
Assessment of lung haemodynamics using the data of echocardiography
Time frame: Up to 12 months
Assessment of lung haemodynamics using the data of catheterization
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Time frame: Up to 12 months
Reason for omission of inhalation as assessed by the physician
Time frame: Up to 12 months
Concomitant medication for other indications than pulmonary hypertension
Time frame: Up to 12 months
Number of participants with adverse events (AEs)
Time frame: Up to 12 months
Severity of AEs
Time frame: Up to 12 months
AE relation to treatment
Time frame: Up to 12 months
AE treatment
Time frame: Up to 12 months
AE outcomes
Time frame: Up to 12 months